Session 1 - Applied Science of Chromatography
Session Chair: Dr. Nelu Grinberg, Boehringer-Ingelheim Pharmaceuticals, Inc. |
A New Approach to Retaining Hydrophilic Compounds in HPLC
|
Professor Joe Pesek, San Jose State University |
Ultra-High Pressure Liquid Chromatography
|
Professor James Jorgenson, University of North Carolina |
| Mechanistic Aspects of Chiral Discrimination on Polysacharides Phases |
Nelu Grinberg, Boehringer Ingelheim Pharmaceutical, Inc. |
Session 2 - Analyzing Complex Mixtures
Session Chair: Dr. David Stranz, Sierra Analytics,
Dr. Ioana Popa-Burke, GlaxoSmithKline |
| FT-ICR MS Sheds Light on Nature's Complexity |
Ryan P. Rodgers, Florida State University |
| Analysis of Perfluorinated Compounds in Complex Environmental and Biological Matrices |
Mark Strynar, EPA |
| Comprehensive Metabolomic Profiling for Understanding the Mechanisms of Diabetes and Obesity |
Michael Muehlbauer, Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center |
Session 3 - Making Unknowns Known
Session Chair: Melissa Gomez, GlaxoSmithKline |
| Finding and Identifying Metabolites: Why Resolution and Accurate Mass Matters |
Kevin Bateman, Merck Frost |
| Library Searching without Libraries |
Dan Sweeney, MathSpec |
Structure Elucidation and Metabolomics
– Presentation not available |
Eric Milgram, Metabolon, Inc. |
Session 4 - New Directions in Pharmaceutical Profiling
Session Chair: Dr. Oliver McConnell, Wyeth Research |
| Impact of ADME/TOX in Drug Discovery: Past, Present and Future |
Li Di, Wyeth Research |
| Future Trends in Drug Discovery: The New Drug Metabolism Scientists |
Dr. Theresa Wilson, Pfizer |
| Non-Conventional Approach to Solubility Measurement without Filtration by an In Situ UV Fiber Optic Method and the Effects of Excipients on Solubility of Sparingly Soluble Compounds Konstantine |
Tsinman , pION Inc. |
Session 5 - Novel Technologies: "Alternatives In The Face of Chemical Diversity"
Session Chair: Michael Balogh, Waters Corporation |
Lead Optimization in a Nano-Droplet: Leveraging Orthogonal Technologies to Improve Throughput for Drug Discovery
|
Paul Schnier, Amgen |
| Investigation of the Potential of IMS and FAIMS for the Measurement of Trace Level Impurities in Formulated Drug Products |
Alice Laures, GlaxoSmithKline |
| Overcoming Signal Suppression and Other Matrix Effects in LC-MS Using Electron Ionization |
Professor Achille Cappiello, University of Urbino |
Excellence In Science Award Winner
Douglas Kiehl, Eli Lilly & Company |